Accelerating Medicines Partnership launches data knowledge portal for Parkinson's disease

(NIH/National Institute of Neurological Disorders and Stroke) The Accelerating Medicines Partnership (AMP) program for Parkinson's disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective therapies for the disease. The portal enables researchers to study complex data sets and perform genome-wide analyses at a scale previously impossible.